Spots Global Cancer Trial Database for opscc
Every month we try and update this database with for opscc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer | NCT04572100 | Oropharyngeal S... | Transoral Robot... Chemotherapy an... Chemotherapy an... Paclitaxel Carboplatin | 18 Years - | University of Chicago | |
| Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer | NCT03715946 | Carcinoma, Squa... Oropharynx Squa... | Nivolumab Injec... Radiotherapy (R... | 18 Years - | University of Pittsburgh | |
| Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer | NCT03715946 | Carcinoma, Squa... Oropharynx Squa... | Nivolumab Injec... Radiotherapy (R... | 18 Years - | University of Pittsburgh | |
| The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial) | NCT05419089 | HPV-positive Or... | Robotic surgery | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial) | NCT05419089 | HPV-positive Or... | Robotic surgery | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC | NCT04564989 | Oropharyngeal S... Carcinoma, Squa... Head and Neck S... Oropharynx Squa... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | ||
| Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell | NCT02663583 | Cancer of the M... Oropharynx Squa... | Symptom Questio... Dysphagia Inven... Activity Bands | 18 Years - | M.D. Anderson Cancer Center | |
| Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer | NCT03258008 | Malignant Neopl... Malignant Neopl... Oropharyngeal C... | Utomilumab ISA101b | 18 Years - | M.D. Anderson Cancer Center | |
| Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell | NCT02663583 | Cancer of the M... Oropharynx Squa... | Symptom Questio... Dysphagia Inven... Activity Bands | 18 Years - | M.D. Anderson Cancer Center | |
| Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC | NCT04564989 | Oropharyngeal S... Carcinoma, Squa... Head and Neck S... Oropharynx Squa... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | ||
| Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer | NCT03715946 | Carcinoma, Squa... Oropharynx Squa... | Nivolumab Injec... Radiotherapy (R... | 18 Years - | University of Pittsburgh | |
| A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer | NCT04916002 | Merkel Cell Car... Cutaneous Squam... Basal Cell Carc... Triple Negative... Non-Small Cell ... Oropharynx Squa... | vidutolimod cemiplimab | 18 Years - | Regeneron Pharmaceuticals |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
